IntelGenx Technologies (IGXT) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free IGXT Stock Alerts $0.17 -0.01 (-5.71%) (As of 04/19/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIntelGenx Technologies Corp. (OTCMKTS:IGXT) Short Interest Updateamericanbankingnews.com - April 11 at 3:14 AMIntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK’ Clinical Trialfinance.yahoo.com - April 8 at 9:23 AMIntelGenx Announces First Parkinson's Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK' Clinical Trialglobenewswire.com - April 8 at 7:45 AMIntelGenx Updates Status of Buprenorphine Buccal Film ANDAglobenewswire.com - April 5 at 7:45 AMIntelGenx Technologies Corp. (IGXT) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 23 at 5:02 PMIntelGenx Technologies Corp. (PNK:IGXT) Q4 2023 Earnings Call Transcriptinsidermonkey.com - March 22 at 3:06 PMIGXT Stock Earnings: Intelgenx Technologies Reported Results for Q4 2023investorplace.com - March 21 at 2:05 PMIntelGenx Reports Fourth Quarter and Full-Year 2023 Financial Resultsglobenewswire.com - March 21 at 7:30 AMIGXT IntelGenx Technologies Corp.seekingalpha.com - March 16 at 11:39 PMIntelGenx to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 – Conference Call to Followglobenewswire.com - March 14 at 4:30 PMIntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life Sciencesglobenewswire.com - March 11 at 7:45 AMUPDATE -- IntelGenx Launches Preferred Share Regulation A Offeringfinance.yahoo.com - February 20 at 3:08 PMUPDATE -- IntelGenx Launches Preferred Share Regulation A Offeringglobenewswire.com - February 20 at 10:50 AMIntelGenx Launches Preferred Share Regulation A Offeringglobenewswire.com - February 20 at 7:50 AMIntelGenx Technologies Corp. (IGXT)finance.yahoo.com - February 19 at 6:51 PMStudies Validate Advantages of Administering Drugs to Pets via IntelGenx’s VetaFilm® Platformfinance.yahoo.com - February 5 at 8:45 AMIntelgenx Technologies Corp IGXTmorningstar.com - December 7 at 3:22 PMIntelGenx Receives Approval to Conduct ’MONTPARK’ Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson's Diseasefinance.yahoo.com - November 14 at 12:22 PMIntelGenx Reminds Shareholders to Vote at Upcoming Special Meetingfinance.yahoo.com - November 13 at 8:45 AMIntelGenx Technologies Corp. (PNK:IGXT) Q3 2023 Earnings Call Transcriptinsidermonkey.com - November 10 at 3:04 PMIntelGenx Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 9 at 4:28 PMIntelGenx Announces Co-development and Commercialization of Cannabinoid-Infused VersaFilm® Products with Tilrayfinance.yahoo.com - November 6 at 8:52 AMIntelGenx Provides RIZAFILM® U.S. Commercialization Updatefinance.yahoo.com - September 21 at 8:28 AMIntelGenx Announces Closing of First Tranche of Non-Brokered Private Placement From Strategic Partner for Approximate Aggregate Gross Proceeds of US$3 Million (Including US$750,000 to be Received by the Company Once Shareholder Approvals Have Been Obtained)finance.yahoo.com - August 31 at 6:52 PMIntelGenx Technologies Corp.: IntelGenx Reports Second Quarter 2023 Financial Resultsfinanznachrichten.de - August 16 at 2:44 AMIntelGenx Technologies Corp. (PNK:IGXT) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 15 at 4:43 PMIntelGenx Technologies Corp. (IGXT) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 15 at 4:43 PMIntelGenx Reports Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 14 at 6:29 PMIntelGenx Announces First Agreement for CDMO Packaging Servicesfinance.yahoo.com - August 10 at 7:40 PMIntelGenx to Report Second Quarter 2023 Financial Results on August 14, 2023 – Conference Call to Followfinance.yahoo.com - August 8 at 8:05 AMIntelGenx Completes Enrollment for ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Diseasefinance.yahoo.com - August 1 at 5:54 PMIntelGenx Announces a Change to its Board of Directorsfinance.yahoo.com - July 21 at 6:51 PMIntelGenx Announces Voting Results on Election of Directorsfinance.yahoo.com - July 6 at 7:11 PMIGXT - IntelGenx Technologies Corp.uk.finance.yahoo.com - June 16 at 1:42 PMIntelGenx Receives Amended DEL License to Conduct Third-Party Testingfinance.yahoo.com - May 17 at 12:28 PMFDA Gives Nod To IntelGenx's Migraine Solution As Revenues Plunge 32%; Q1 Results Reportmsn.com - May 11 at 9:32 PMIntelGenx Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - May 11 at 4:31 PMIntelGenx to Report First Quarter 2023 Financial Results on May 11, 2023 – Conference Call to Followfinance.yahoo.com - May 4 at 8:55 PMClosing Bell: Intelgenx Technologies Corp down on Friday (IGX)theglobeandmail.com - April 22 at 10:44 AMClosing Bell: Intelgenx Technologies Corp down on Tuesday (IGX)theglobeandmail.com - April 19 at 2:16 AMIntelGenx Technologies Corp.: IntelGenx Announces FDA Approval of RIZAFILM for the Treatment of Acute Migrainefinanznachrichten.de - April 17 at 3:13 PMIntelGenx Announces FDA Approval of RIZAFILM® for the Treatment of Acute Migrainefinance.yahoo.com - April 17 at 10:12 AMIntelGenx Technologies Corp.: IntelGenx Announces Organizational Changes to Support Global Growth Strategyfinanznachrichten.de - April 13 at 12:51 PMIntelGenx Technologies Corp. (PNK:IGXT) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - April 1 at 2:28 PMIntelGenx Technologies Corp.: IntelGenx Reports Fourth Quarter and Full-Year 2022 Financial Resultsfinanznachrichten.de - March 30 at 8:33 PMCORRECTION - IntelGenx to Participate in the 35th Annual Roth Conferencestockhouse.com - March 12 at 12:02 AMIntelGenx Receives USPTO Notice of Allowance for Loxapine Orange Book Eligible Patentfinance.yahoo.com - February 21 at 10:21 AMIntelGenx Announces Research Collaboration with Renowned Neurologist to Evaluate Montelukast VersaFilm® for the Treatment of Parkinson’s Diseasefinance.yahoo.com - February 9 at 9:28 AMIntelGenx and Arwan Enter into a Supply Agreement for RIZAPORT® in MENA Countriesfinance.yahoo.com - January 23 at 11:56 AMIntelGenx Announces Collaboration with UPEI to Evaluate Acceptance and Preference of VetaFilm™ Platform in Dogs and Catsfinance.yahoo.com - December 7 at 8:05 AM Get IntelGenx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IGXT and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. IGXT Media Mentions By Week IGXT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IGXT News Sentiment▼0.980.51▲Average Medical News Sentiment IGXT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IGXT Articles This Week▼00▲IGXT Articles Average Week Get IntelGenx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IGXT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Acurx Pharmaceuticals News Today Lipocine News Today Aptorum Group News Today Spruce Biosciences News Today Eyenovia News Today Acasti Pharma News Today Aileron Therapeutics News Today Aprea Therapeutics News Today DURECT News Today Alaunos Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IGXT) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceOptions trading has suddenly become more reliable.Eagle PublishingHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IntelGenx Technologies Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.